3.10 Colon Cancer Screening, Vascepa Patent with Jonathan Darrow, PREVENTT with Dr. Toby Richards

Plenary Session

Vinay Prasad, MD MPH

Health, Medicine, Policy, Oncology, Science & Medicine

4.7 • 789 Ratings

🗓️ 5 September 2020

⏱️ 122 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

We have a number of topics for you this week! Among them, we cover the issue of colon cancer screening, especially in the light of Chadwick Boseman's recent passing. We interview Jonathan Darrow, an Assistant Professor at Harvard Medical School and faculty at Brigham and Women's Hospital, on patent litigation and the recent patent appeal for Vascepa. Finally, we interview Dr. Toby Richards, Professor of Surgery, on running clinical trials and, specifically, the results of his recent trial PREVENTT, out now in The Lancet. PREVENTT: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31539-7/fulltext Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew

Transcript

Click on a timestamp to play from that location

0:00.0	Welcome. I'm Dr. Vinay Prasad. I'm a hematologist, oncologist, and I'm associate professor of medicine at the University of California, San Francisco. In my professional life, I see patients, I teach trainees, and I do research in health care policy. This is plenary session. Plenary session is a
0:24.0	podcast at the intersection of medicine, oncology, and health policy. And you're listening to
0:28.5	season three on this week's episode. This week on plenary session, you're in for a real treat. I've got two
0:35.9	guests for you. I got Jonathan Darrow.
0:38.0	He's an expert in patent litigation and patent law, and he's on the faculty of the Harvard
0:42.3	Medical School.
0:43.1	And he's going to talk about the patent dispute around a very popular fish oil derivative
0:48.9	product, a slice of a fish, called Vasepa.
0:52.2	You won't want to miss this discussion about patents. Next, I've got
0:55.8	Toby Richards, and he is the first author on a new paper called Prevent. It's out in the Lancet.
1:01.2	It is a randomized control trial of whether or not patients scheduled for major abdominal surgery
1:05.4	should get a slug of IV iron two weeks before that surgery. You won't want to miss this
1:10.0	discussion and what it's like to be a trialist
1:12.2	who runs a trial for a decade.
1:14.1	So, you won't want to miss this discussion.
1:16.4	And first, I have a monologue
1:17.8	where I'm going to hit on a number of topics.
1:19.6	You won't want to miss today's episode.
1:21.2	Stay tuned.
1:34.1	If you like this podcast and want more content, follow me on Twitter at Viprasad MDMPH.
1:38.1	Check out the YouTube channel, Vinayprasad, MDMPH.
1:42.5	Patreon backers will get access to the slides for lectures I give on plenary session.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Vinay Prasad, MD MPH, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Vinay Prasad, MD MPH and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.